In This Article:
It's been a good week for Siemens Healthineers AG (ETR:SHL) shareholders, because the company has just released its latest annual results, and the shares gained 8.0% to €52.20. It looks like the results were a bit of a negative overall. While revenues of €22b were in line with analyst predictions, statutory earnings were less than expected, missing estimates by 3.2% to hit €1.73 per share. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.
Check out our latest analysis for Siemens Healthineers
Following the latest results, Siemens Healthineers' 16 analysts are now forecasting revenues of €23.7b in 2025. This would be a credible 6.0% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to surge 23% to €2.14. In the lead-up to this report, the analysts had been modelling revenues of €23.8b and earnings per share (EPS) of €2.20 in 2025. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a minor downgrade to their earnings per share forecasts.
The consensus price target held steady at €59.35, with the analysts seemingly voting that their lower forecast earnings are not expected to lead to a lower stock price in the foreseeable future. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Siemens Healthineers, with the most bullish analyst valuing it at €65.90 and the most bearish at €50.00 per share. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.
One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that Siemens Healthineers' revenue growth is expected to slow, with the forecast 6.0% annualised growth rate until the end of 2025 being well below the historical 10% p.a. growth over the last five years. Compare this to the 14 other companies in this industry with analyst coverage, which are forecast to grow their revenue at 6.0% per year. So it's pretty clear that, while Siemens Healthineers' revenue growth is expected to slow, it's expected to grow roughly in line with the industry.